Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic among drugs selected for Medicare price negotiations
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from cancer and type 2 diabetes to asthma.
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
15 Costly Medicare Drugs Selected for Next Round of Price Negotiations
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations for 10 drugs whose lower prices take effect in 2026. T
2h
on MSN
5 2025 Medicare Changes Every Retiree Should Know
Medicare premiums and deductibles have increased for all retirees. There's now a $2,000 cap on annual out-of-pocket ...
1d
on MSN
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
1d
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
2d
on MSN
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...
Modern Healthcare
1d
Medicare spending, insurance claim denials top concerns: KFF poll
Survey respondents pointed to federal health program spending, price transparency regulation and drug price negotiations as ...
2d
The Medicare maze: Finding providers in a shrinking network
It can be harder than ever for older Americans to find providers who accept Medicare at all, let alone those who are taking ...
JD Supra
2d
Outlook for Medicare Advantage Under the Trump Administration
Medicare Advantage (MA), the private insurance option under Medicare, is one of many policy areas that will garner great ...
2d
on MSN
Scott Bessent: Trump has said social security and medicare will not be touched
The Senate Finance Committee holds a confirmation hearing for Scott Bessent, President-elect Donald Trump’s pick for the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback